Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
June 21 2024 - 3:30AM
Audrey Duval Derveloy appointed Global Head of
Corporate Affairs, member of Sanofi’s Executive Committee
Paris, June 21, 2024. Audrey
Duval Derveloy, a seasoned healthcare industry leader and Sanofi
France’s President, has been named Executive Vice President, Global
Head of Corporate Affairs. Audrey will become a member of Sanofi’s
Executive Committee, reporting into CEO Paul Hudson, and will be
based in Paris. Her appointment is effective July 1, 2024.
In her new role, Audrey will be responsible for
Sanofi’s stakeholder engagement globally, and oversee the company’s
corporate social responsibility strategy, not-for-profit Global
Health Unit and Sanofi’s philanthropic arm, Foundation S. Audrey
retains her role as President, Sanofi France, and will continue
supporting and coordinating Sanofi’s representation to its various
external stakeholders in this country.
Paul HudsonChief Executive
Officer, Sanofi“ I am very pleased to have Audrey join our
Executive Committee. Over the last two years, her leadership has
been instrumental in advancing our company’s modernization in
France. She has supported our strategic priorities and helped
showcase Sanofi as a leading healthcare company in our home market.
This recent experience, coupled with her business acumen and
ability to inspire and motivate teams, paves the way for her to
drive our global external engagement strategy and play a decisive
part in our ambitions to become a science-driven company
transforming the practice of medicine for patients across the
world.”
Audrey joined Sanofi from Novartis to serve as
President, Sanofi France, in September 2022. A physician by
training, she started her career in public hospitals in Paris. She
then worked as a Researcher at the Pasteur Research Center of Hong
Kong University and later as a Scientific Expert at Salusmed, based
in Hong Kong. She returned to France to join Pfizer, working in
medical affairs in the areas of Endocrinology, Transplant and
Rheumatology. Audrey later joined Novartis in France, where she
progressively advanced to become Business Franchise Head for
Ophthalmology and then, in 2020, Country President for the
company’s operations in Ireland. Audrey holds a Medical Doctorate
from the Paris Faculté de Médécine Cochin, and a Bachelor of
Science in Medical Biology.
Audrey Duval DerveloyExecutive
vice-president, Global Head of Corporate Affairs, Sanofi“For the
past two years, I have witnessed every day the unwavering
commitment of our employees in France to serving patients around
the world. Behind each of our successes, from the launch of
Beyfortus against RSV, to the environmental transition of our
industrial sites, to the mobilization of thousands of employees in
support of our partnership with Paris 2024, we had the Corporate
Affairs teams at our side. It is with the strength of these
successes in mind that I take on these new responsibilities as we
continue to modernize Sanofi and pursue our ambition to become an
immunology powerhouse.”
About SanofiWe are an innovative global
healthcare company, driven by one purpose: we chase the miracles of
science to improve people’s lives. Our team is dedicated to
transforming the practice of medicine by working to turn the
impossible into the possible. We provide potentially life-changing
treatment options and life-saving vaccine protection to millions of
people globally, while putting sustainability and social
responsibility at the center of our ambitions. Sanofi is listed on
EURONEXT: SAN and NASDAQ: SNY
Media RelationsSandrine
Guendoul | + 33 6 25 09 14 25
| sandrine.guendoul@sanofi.comNicolas
Obrist | + 33 6 77 21 27 55 |
nicolas.obrist@sanofi.comVictor
Rouault | + 33 6 70 93 71 40
| victor.rouault@sanofi.comEvan Berland | +1
215 432 0234 | evan.berland@sanofi.comTimothy
Gilbert | + 1 516 521 2929 |
timothy.gilbert@sanofi.com
Investor RelationsThomas Kudsk
Larsen |+ 44 7545 513 693 |
thomas.larsen@sanofi.comAlizé
Kaisserian | + 33 6 47 04 12 11 |
alize.kaisserian@sanofi.comArnaud
Delépine | + 33 6 73 69 36 93 |
arnaud.delepine@sanofi.comFelix
Lauscher | + 1 908 612 7239 |
felix.lauscher@sanofi.comKeita
Browne | + 1 781 249 1766 |
keita.browne@sanofi.comNathalie Pham | +
33 7 85 93 30 17 | nathalie.pham@sanofi.comTarik
Elgoutni | + 1 617 710 3587 |
tarik.elgoutni@sanofi.comThibaud Châtelet | + 33 6
80 80 89 90 | thibaud.chatelet@sanofi.com
- Press_Release
- Photo_Audrey_Duval_Derveloy
Sanofi (EU:SAN)
Historical Stock Chart
From May 2024 to Jun 2024
Sanofi (EU:SAN)
Historical Stock Chart
From Jun 2023 to Jun 2024